Stock Financial Ratios

ALT / Altimmune, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price1.52
Volume95,800.00
Market Cap ($M)24.89
Enterprise Value ($M)7.11
Book Value ($M)19.46
Book Value / Share0.28
Price / Book0.48
NCAV ($M)16.99
NCAV / Share0.25
Price / NCAV1.70
Income Statement (mra) ($M)
Revenue0.00
EBITDA-11.26
Net Income193.85
Balance Sheet (mrq) ($M)
Cash & Equivalents0.00
Cash / Share0.00
Assets0.00
Liabilities0.00
Quick Ratio1.09
Current Ratio1.09
Management Effectiveness (mra)
Return on Invested Capital (ROIC)9.96
Return on Assets (ROA)9.76
Return on Equity (ROE)11.64
Identifiers and Descriptors
CUSIP02155H101
Central Index Key (CIK)1326190
Industry Groups
SIC 2834 - Pharmaceutical Preparations
Other Related CUSIPS
71714G902
71714G102
71714G952
Share Statistics
Common Shares Outstanding68,815,195
Common Stock Shares Outstanding67,726,458
Weighted Average Number Of Diluted Shares Outstanding65,657,802
Weighted Average Number Of Shares Outstanding Basic65,306,962
Scoring Models
Piotroski F-Score3.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Kaplan-Zingales KZ-IndexN/A
Cash Conversion CycleN/A
Per Share Metrics
Retained Earnings Per Share0.00
Liabilities And Stock Equity Per Share0.00
Assets Other Non Current Per Share0.00
Intangibles Per Share0.56
Goodwill Per Share0.00
Property Plant And Equipment Net Per Share0.00
Liabilities Current Per Share0.00
Assets Per Share0.00
Deferred Income Tax Liabilities Per Share0.00
Current Portion Of Long Term Debt Per Share0.00
Property Plant And Equipment Gross Per Share0.00
Accounts Receivable Per Share0.00
Property Plant And Equipment Per Share0.00
Inventory Raw Materials Per Share0.00
Liabilities Per Share0.00
Cash And Equivalents Per Share0.00
Assets Other Current Per Share0.00
Inventory Finished Goods Per Share0.00
Liabilities Other Non Current Per Share0.00
Preferred Stock Value Outstanding Per Share0.00
Assets Non Current Per Share0.00
Accumulated Depreciation And Depletion Per Share0.00
Equity Per Share0.00
Assets Current Per Share0.00
Minority Interest Per Share0.00
Inventory Work In Progress Per Share0.00
Additional Paid In Capital Per Share0.00
Long Term Debt Per Share0.00
Treasury Stock Per Share0.00
Cash Per Share0.00
Accounts Payable Per Share0.00
Debt Per Share0.00
Inventory Per Share0.00

Peers - Pharmaceutical Preparations (2834)

Related News Stories

Altimmune's (ALT) CEO Bill Enright on Q3 2017 Results - Earnings Call Transcript

2017-11-10 seekingalpha
Good day and welcome to the Altimmune Inc. Third Quarter 2017 Earnings Conference Call. Today’s call is being recorded. At this time, I would like to turn the conference over to Ashley Robinson. Please go ahead, sir. (2-1)

CUSIP: 02155H101